James Tracy, DO
Allergy & Immunology · Omaha, NENPI 1801888300
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 47 manufacturers reported payments, led by Consortium Of Independent Immunology Clinics, LLC at 35.6% of the total. 2025 is the largest year on record at $41,369, 3.3 times the $12,538 reported in 2019. Among allergy & immunology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 805 payments — averaging $129.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Consortium Of Independent Immunology Clinics, LLC$37K
- Ionis Pharmaceuticals, Inc.$12K
- Genentech USA, Inc.$11K
- Pharming Healthcare, Inc.$9K
- Jubilant Hollisterstier LLC$5K
- Grifols USA, LLC$5K
- plus $25K from 41 others
Across 1 payment — averaging $5250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Consortium Of Independent Immunology Clinics, LLC$5K
Across 2 payments — averaging $5547.35 each. An ownership or investment interest held by the physician or an immediate family member.
- Consortium Of Independent Immunology Clinics, LLC$11K
What the payments were for
- Consulting fees$47,45846%
- Speaking & faculty fees$30,60629%
- Grants$5000%
- Travel & lodging$5,7886%
- Food & beverage$19,28219%
- Education$4310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$104,065 in reported general payments places this provider in the 95th percentile of 21 allergy & immunology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrladeyoBerotralstat Hydrochloride | 25 | $1,069,145 |
| Dupixent PenDupilumab | 31 | $174,528 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $48,953 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $16,522 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $6,749 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $5,943 |
| Arnuity ElliptaFluticasone Furoate | 13 | $5,099 |
| Advair DiskusFluticasone Propion/Salmeterol | 18 | $4,059 |
| Montelukast Sodium | 493 | $3,515 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 23 | $3,273 |
| Epinephrine | 12 | $2,090 |
| Fluticasone Propionate | 118 | $1,323 |
| Azelastine Hcl | 59 | $1,240 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $914 |
| Hydroxyzine Hcl | 27 | $692 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Biocryst US Sales Co., LLCOrladeyo | $2,744 | $1,069,14525 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $580 | $60,80084 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $3,303 | $22,46547 claims |
| Hikma Pharmaceuticals USAEpinephrine | $32 | $2,09012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 allergy & immunology providers in Nebraska.
Other allergy & immunology in Omaha
- Roger KobayashiOmaha$45K
- Mitchell PitlickOmaha$26K
- James FriedlanderOmaha$22K
- Brett KettelhutOmaha$21K
- Teodoro SeguraOmaha$8K
- Gary KoenigOmaha$4K
- Sara MayOmaha$2K
- Brian KellyOmaha$1K
- Jose Zamora SifuentesOmaha$786
- Joel van de GraaffOmaha$692
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.